Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Cancer Epidemiol Biomarkers Prev ; 29(8): 1647-1653, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32430338

RESUMEN

BACKGROUND: Experimental evidence suggests that dietary intakes of omega-3 and omega-6 polyunsaturated fatty acids have divergent effects on melanoma growth, but epidemiologic evidence on their combined effect is lacking. METHODS: In 634 Australian patients with primary melanoma, we assessed prediagnosis consumption of 39 food groups by food frequency questionnaires completed within 2 months of diagnosis. We derived, by reduced rank regression, dietary patterns that explained variability in selected omega-3 and omega-6 fatty acid intakes. Prevalence ratios (PR) and 95% confidence intervals (CI) for the association between tertiles of dietary patterns and melanoma thickness >2 mm versus ≤2 mm were estimated using Poisson regression. RESULTS: Overall omega-3 fatty acid intakes were low. Two major fatty acid dietary patterns were identified: "meat, fish, and fat," positively correlated with intakes of all fatty acids; and "fish, low-meat, and low-fat," positively correlated with long-chain omega-3 fatty acid intake, and inversely with medium-chain omega-3 and omega-6 fatty acid intakes. Prevalence of thick melanomas was significantly higher in those in the highest compared with lowest tertile of the "meat, fish, and fat" pattern (PR, 1.40; 95% CI, 1.01-1.94), especially those with serious comorbidity (PR, 1.83; 95% CI, 1.15-2.92) or a family history (PR, 2.32; 95% CI, 1.00-5.35). The "fish, low-meat, and low-fat" pattern was not associated with melanoma thickness. CONCLUSIONS: People with high meat, fish, and fat intakes, who thus consumed relatively high levels of omega-3 and high omega-6 fatty acid intakes, are more likely to be diagnosed with thick than thin melanomas. IMPACT: High omega-3 and omega-6 fatty acid intakes may contribute to patients' presentation with thick melanomas.


Asunto(s)
Ácidos Grasos Omega-3/uso terapéutico , Ácidos Grasos Omega-6/uso terapéutico , Melanoma/dietoterapia , Ácidos Grasos Omega-3/farmacología , Ácidos Grasos Omega-6/farmacología , Femenino , Humanos , Masculino
2.
Nutr Cancer ; 67(7): 1049-55, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26359536

RESUMEN

Tea consumption has been shown to protect against skin carcinogenesis in laboratory-based studies; however, epidemiological evidence is limited and inconsistent. This prospective study examined the association between black tea consumption and the incidence of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Usual black tea consumption was estimated from food frequency questionnaires completed in 1992, 1994, and 1996 by 1,325 Australian adults. All histologically confirmed skin cancers diagnosed in participants from 1997 to 2007 were recorded. Relative risks (RRs) and 95% confidence intervals (CIs) were assessed using generalized linear models with Poisson and negative binomial distributions and adjusted for confounding factors including skin phenotype and sun exposure. Compared with never drinking black tea, drinking ≥4 cups/day was not associated with BCC (RR = 1.03, 95% CI: 0.70-1.53; P-trend = 0.74) or SCC (RR = 1.25, 95% CI: 0.71-2.19; P-trend = 0.29) in person-based analyses. Stratification by previous history of skin cancer as well as tumor-based analyses also showed no significant associations between black tea intake and incidence of BCC or SCC tumors. Our results do not support the hypothesis that high black tea consumption reduces risk of skin cancer, including in people with a previous history of skin cancer.


Asunto(s)
Carcinoma Basocelular/epidemiología , Carcinoma de Células Escamosas/epidemiología , Neoplasias Cutáneas/epidemiología , , Adulto , Carcinoma Basocelular/etiología , Carcinoma de Células Escamosas/etiología , Intervalos de Confianza , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Queensland/epidemiología , Neoplasias Cutáneas/etiología
3.
Br J Nutr ; 111(8): 1430-40, 2014 Apr 28.
Artículo en Inglés | MEDLINE | ID: mdl-24331201

RESUMEN

Phyto-oestrogens have been suggested to have a protective effect on hormone-sensitive cancers. However, few studies have investigated the association between dietary phyto-oestrogens and gynaecological cancers. In the present study, we analysed data from two population-based case-control studies of ovarian (1366 cases and 1414 controls) and endometrial (1288 cases and 1435 controls) cancers. Dietary intake information was obtained using a 135-item FFQ, and phyto-oestrogen intake was estimated using published food composition databases. Unconditional logistic regression was used to estimate adjusted OR and 95% CI. In multivariable analyses, there was a suggestive pattern of inverse associations between increasing intakes of total phyto-oestrogens, isoflavones and enterolignans and the risk of ovarian cancer. However, the results only reached statistical significance for the lignan compounds matairesinol and lariciresinol, where the OR for the highest v. the lowest intake category was 0.72 (95% CI 0.54, 0.96; P for trend = 0.02) for matairesinol and 0.72 (95% CI 0.55, 0.96; P for trend = 0.03) for lariciresinol. When the risk of ovarian cancer was assessed by subtype, there was an indication that increasing intakes of phyto-oestrogens may be associated with a decreased risk of mucinous (cases n 158) ovarian tumours (OR for the highest v. the lowest intake category: 0.47 (95% CI 0.24, 0.93); P for trend = 0.04). However, there were no significant associations with other histological subtypes. In contrast, dietary phyto-oestrogens (total or any subclass) were unrelated to the risk of endometrial cancer cases overall or by subtype.


Asunto(s)
Adenocarcinoma Mucinoso/prevención & control , Dieta , Neoplasias Endometriales , Isoflavonas/uso terapéutico , Lignina/uso terapéutico , Neoplasias Ováricas/prevención & control , Fitoestrógenos/uso terapéutico , Anciano , Australia , Estudios de Casos y Controles , Encuestas sobre Dietas , Neoplasias Endometriales/prevención & control , Femenino , Furanos/farmacología , Furanos/uso terapéutico , Humanos , Isoflavonas/farmacología , Lignanos/farmacología , Lignanos/uso terapéutico , Lignina/farmacología , Modelos Logísticos , Persona de Mediana Edad , Oportunidad Relativa , Fitoestrógenos/farmacología , Encuestas y Cuestionarios
4.
Eur J Nutr ; 53(2): 511-20, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-23824258

RESUMEN

PURPOSE: Caffeine may repair skin damage induced by excessive exposure to ultraviolet light. The purpose of this study was to investigate the association between caffeine intake and incidence of basal cell (BCC) and squamous cell carcinoma (SCC). We also assessed the associations between coffee consumption and incidence of these skin cancers. METHODS: Caffeine intake and consumption of coffee were estimated from food frequency questionnaires assessed in 1992, 1994, and 1996 among 1,325 randomly selected adult residents of a subtropical Australian community. All histologically confirmed tumours of BCC and SCC occurring between 1997 and 2007 were recorded. Associations with BCC and SCC were assessed using Poisson and negative binomial regression models and were adjusted for confounders including skin type and indicators of past sun exposure. RESULTS: There was no association between total caffeine intake and incidence of BCC or SCC. Participants with prior skin cancers, however, had a 25% lower risk of BCC if they were in the highest tertile of total caffeine intake (equivalent to daily consumption of four cups of regular coffee) compared with the lowest tertile (multivariable RR 0.75; 95% CI 0.57-0.97, P trend = 0.025). There was no dose-response relationship with SCC. Consumption of neither caffeinated nor decaffeinated coffee was associated with BCC or SCC. CONCLUSIONS: Among people with prior skin cancers, a relatively high caffeine intake may help prevent subsequent BCC development. However, caffeine intake appears not to influence the risk of SCC.


Asunto(s)
Cafeína/administración & dosificación , Carcinoma Basocelular/epidemiología , Carcinoma de Células Escamosas/epidemiología , Dieta , Neoplasias Cutáneas/epidemiología , Adulto , Anciano , Australia/epidemiología , Café , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ocupaciones , Estudios Prospectivos , Factores de Riesgo , Factores Sexuales , Pigmentación de la Piel , Fumar/efectos adversos , Quemadura Solar , Luz Solar/efectos adversos , Encuestas y Cuestionarios
5.
Cancer Epidemiol Biomarkers Prev ; 22(10): 1900-5, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23885039

RESUMEN

Laboratory-based evidence suggests that omega-3 and omega-6 polyunsaturated fatty acids may affect skin photocarcinogenesis, but epidemiologic evidence is inconsistent. In 1,191 White Australian adults, we prospectively investigated associations between baseline plasma concentrations of omega-3 and omega-6 fatty acids and cutaneous basal cell carcinomas (BCC) and squamous cell carcinomas (SCC). Relative risks (RR) and 95% confidence intervals (CI) were estimated on the basis of number of histologically confirmed tumors diagnosed during follow-up (1997-2007). Plasma eicosapentaenoic acid (EPA) concentrations and omega-3/-6 ratio showed significant inverse associations with SCC tumors, comparing higher tertiles with the lowest, in age- and sex-adjusted models (Ptrend = 0.02 and 0.03, respectively) which weakened after adjustment for past sun exposure. Associations between EPA and SCC were stronger among participants with a history of skin cancer at baseline (n = 378; highest vs. lowest tertile: RR = 0.50; 95% CI, 0.28-0.92; Ptrend = 0.01). Total omega-6 was inversely associated with BCC tumors in multivariate models (P = 0.04; highest vs. lowest tertile: RR = 0.71; 95% CI, 0.51-0.99), and more strongly in the subgroup with past skin cancer. Linoleic and linolenic acids were also inversely associated with BCC occurrence in this subgroup. When fatty acids were analyzed as continuous variables, however, there was no evidence of any linear or nonlinear associations. This study provides some support for reduced skin cancer risk with high plasma concentrations of omega-3 and omega-6 fatty acids, but results depended on how fatty acid data were modeled. Further investigation of these associations in larger datasets is needed.


Asunto(s)
Carcinoma Basocelular/sangre , Carcinoma de Células Escamosas/sangre , Ácidos Grasos Omega-3/sangre , Ácidos Grasos Omega-6/sangre , Neoplasias Cutáneas/sangre , Australia/epidemiología , Carcinoma Basocelular/epidemiología , Carcinoma de Células Escamosas/epidemiología , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Neoplasias Cutáneas/epidemiología
6.
Ann Intern Med ; 158(11): 781-90, 2013 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-23732711

RESUMEN

BACKGROUND: Sunscreen use and dietary antioxidants are advocated as preventives of skin aging, but supporting evidence is lacking. OBJECTIVE: To determine whether regular use of sunscreen compared with discretionary use or ß-carotene supplements compared with placebo retard skin aging, measured by degree of photoaging. DESIGN: Randomized, controlled, community-based intervention. (Australian New Zealand Clinical Trials Registry: ACTRN12610000086066). SETTING: Nambour, Australia (latitude 26° S). PATIENTS: 903 adults younger than 55 years out of 1621 adults randomly selected from a community register. INTERVENTION: Random assignment into 4 groups: daily use of broad-spectrum sunscreen and 30 mg of ß-carotene, daily use of sunscreen and placebo, discretionary use of sunscreen and 30 mg of ß-carotene, and discretionary use of sunscreen and placebo. MEASUREMENTS: Change in microtopography between 1992 and 1996 in the sunscreen and ß-carotene groups compared with controls, graded by assessors blinded to treatment allocation. RESULTS: The daily sunscreen group showed no detectable increase in skin aging after 4.5 years. Skin aging from baseline to the end of the trial was 24% less in the daily sunscreen group than in the discretionary sunscreen group (relative odds, 0.76 [95% CI, 0.59 to 0.98]). ß-Carotene supplementation had no overall effect on skin aging, although contrasting associations were seen in subgroups with different severity of aging at baseline. LIMITATION: Some outcome data were missing, and power to detect moderate treatment effects was modest. CONCLUSION: Regular sunscreen use retards skin aging in healthy, middle-aged men and women. No overall effect of ß-carotene on skin aging was identified, and further study is required to definitively exclude potential benefit or potential harm. PRIMARY FUNDING SOURCE: National Health and Medical Research Council of Australia.


Asunto(s)
Antioxidantes/uso terapéutico , Suplementos Dietéticos , Envejecimiento de la Piel/efectos de los fármacos , Protectores Solares/uso terapéutico , beta Caroteno/uso terapéutico , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad
7.
Nutrition ; 29(7-8): 1048-53, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23759266

RESUMEN

OBJECTIVE: Vitamin D intake from foods or supplements is a safe and attractive means to improve vitamin D status of populations. The aim of this study was to help identify population subgroups that would benefit most from efforts to increase intake. To do so, we investigated which personal characteristics are associated with vitamin D intake in an Australian population and modeled possible effects of expanded food fortification practices. METHODS: We investigated vitamin D intake in a population-based random sample of 785 adults, using a validated food frequency questionnaire, and assessed associations with personal and behavioral characteristics. We identified vitamin D food sources and modeled the hypothetical effects of blanket fortification of milk and breakfast cereals. RESULTS: Average total vitamin D intake was 4.4 (±4.0) µg/g and below adequate intake for most participants in all age and sex subgroups. Higher intake was associated with being female, having a serious medical condition, energy intake below the median, and vitamin D supplement use (all P < 0.05). The "meat, fish, and eggs" food group contributed most to total vitamin D intake (51%), followed by dairy products and related foods (43%). If all milk and breakfast cereals were to be fortified with vitamin D, the average intake of vitamin D from foods would increase from 3.6 (±2.4) µg/d to 6.3 (±3.2) µg/d, with similar increases in all age and sex subgroups. CONCLUSIONS: Vitamin D intake in Australia is generally below recommended levels, and few personal characteristics help to identify subgroups with low intake. Blanket vitamin D fortification of milk and breakfast cereals would substantially increase average vitamin D intake in Australian adults of all ages.


Asunto(s)
Desayuno , Suplementos Dietéticos , Grano Comestible/química , Alimentos Fortificados , Leche/química , Vitamina D/administración & dosificación , Adulto , Anciano , Anciano de 80 o más Años , Animales , Australia , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Evaluación Nutricional , Ensayos Clínicos Controlados Aleatorios como Asunto , Encuestas y Cuestionarios
8.
Int J Cancer ; 133(1): 214-24, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23292980

RESUMEN

While dietary antioxidants are emerging as potentially modifiable risk factors for esophageal adenocarcinoma (EAC), studies on dietary antioxidants and its precursor Barrett's esophagus (BE) are limited. The present study extends previous work on BE by investigating risks of nondysplastic BE, dysplastic BE and EAC associated with intake of antioxidants such as vitamin C, vitamin E, ß-carotene, and selenium. Age and sex matched control subjects (n=577 for BE; n=1,507 for EAC) were sampled from an Australian population register. Information on demography, and well established EAC risk factors were obtained using self-administered questionnaires. Intake of antioxidants for patients newly diagnosed with nondysplastic BE (n=266), dysplastic BE (n=101), or EAC (n=299), aged 18-79 years, were obtained using a food frequency questionnaire. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using multivariable adjusted logistic regression models. High intake of ß-carotene from food and supplement sources combined was inversely associated with risk of dysplastic BE (OR Q4 vs. Q1=0.45; 95%CI: 0.20-1.00). High intake of vitamin E from food sources (OR Q4 vs. Q1=0.43; 95%CI: 0.28-0.67), from food and supplements combined (OR Q4 vs. Q1=0.64; 95%CI: 0.43-0.96), and a high antioxidant index score were inversely associated with risk of EAC. We found no significant trends between intake of ß-carotene, vitamin C, vitamin E, and selenium and risk of nondysplastic or dysplastic BE. However, our data suggest that a high intake of ß-carotene may be associated with decreased risk of dysplastic BE.


Asunto(s)
Adenocarcinoma/epidemiología , Adenocarcinoma/prevención & control , Antioxidantes/administración & dosificación , Esófago de Barrett/epidemiología , Esófago de Barrett/prevención & control , Neoplasias Esofágicas/epidemiología , Neoplasias Esofágicas/prevención & control , Conducta Alimentaria , Adulto , Anciano , Ácido Ascórbico/administración & dosificación , Australia/epidemiología , Ingestión de Energía , Femenino , Frutas , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Selenio/administración & dosificación , Verduras , Vitamina E/administración & dosificación , beta Caroteno/administración & dosificación
9.
Nutr Cancer ; 64(7): 982-90, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22974045

RESUMEN

Intake of omega-3 and omega-6 fatty acids may modify the risk of basal and squamous cell carcinoma of the skin (BCC and SCC), but population-based evidence is limited and inconsistent. We examined prospectively associations between intake of omega-3 and omega-6 fatty acids estimated from food frequency questionnaires and BCC and SCC incidence among 1322 randomly selected adults in Nambour, Australia. Relative risks (RR) and 95% confidence intervals (CI) were estimated based on histologically confirmed tumors diagnosed between 1997 and 2007. Incidence of BCC was lowest in the middle third of both total omega-6 intake (RR(mv.adj) = 0.74, 95% CI = 0.56-0.97) and linoleic acid intake (RR(mv.adj) = 0.75, 95% CI = 0.57-0.99) compared with the lowest third of intake. Evidence for associations with SCC was weak, though persons with arachidonic acid intake in the middle third had a marginally increased risk of SCC (RR(mv.adj) = 1.42, 95% CI = 1.00-2.02). Consumption of omega-3 fatty acids was not associated with subsequent skin cancer risk. Suggestion that intake of arachidonic acid may be associated with increased SCC incidence and total omega-6 with reduced BCC from our study is still highly uncertain and may be due to chance. These data do not support an association between these fatty acids and risk of BCC or SCC.


Asunto(s)
Carcinoma Basocelular/epidemiología , Carcinoma de Células Escamosas/epidemiología , Ácidos Grasos Omega-3/administración & dosificación , Ácidos Grasos Omega-6/administración & dosificación , Neoplasias Cutáneas/epidemiología , Adulto , Anciano , Australia/epidemiología , Carcinoma Basocelular/prevención & control , Carcinoma de Células Escamosas/prevención & control , Intervalos de Confianza , Ingestión de Energía , Femenino , Humanos , Incidencia , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Análisis Multivariante , Estudios Prospectivos , Factores de Riesgo , Neoplasias Cutáneas/prevención & control , Resultado del Tratamiento
10.
J Nutr ; 141(2): 274-83, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21178085

RESUMEN

Folate plays a key role in DNA synthesis and methylation. Limited evidence suggests high intake may reduce risks of esophageal cancer overall; however, associations with esophageal cancer subtypes and Barrett's esophagus (BE), a precancerous lesion, remain unexplored. We evaluated the relation between intake of folate, B vitamins, and methyl-group donors (methionine, choline, betaine) from foods and supplements, polymorphisms in key folate-metabolizing genes, and risk of BE, esophageal adenocarcinoma (EAC), and esophageal squamous cell carcinoma (ESCC) in 2 population-based case-control studies in Australia. BE patients without (n = 266) or with (n = 101) dysplasia were compared with population controls (n = 577); similarly, EAC (n = 636) or ESCC (n = 245) patients were compared with population controls (n = 1507) using multivariable adjusted logistic regression. Increasing intake of folate from foods was associated with reduced EAC risk (P-trend = 0.01) and mitigated the increased risks of ESCC associated with smoking and alcohol consumption. In contrast, high intake of folic acid from supplements was associated with a significantly elevated risk of BE with dysplasia. High intakes of riboflavin and methionine from food were associated with increased EAC risk, whereas increasing betaine intake was associated with reduced risks of BE without (P-trend = 0.004) or with dysplasia (P-trend = 0.02). Supplemental thiamin, riboflavin, niacin, and vitamin B-12 were associated with increased EAC risk. There were no consistent associations between genetic polymorphisms studied and BE or EAC risk. High intake of folate-containing foods may reduce risk of EAC, but our data raise the possibility that folic acid supplementation may increase risks of BE with dysplasia and EAC.


Asunto(s)
Adenocarcinoma/prevención & control , Esófago de Barrett/prevención & control , Dieta , Neoplasias Esofágicas/prevención & control , Ácido Fólico/uso terapéutico , Complejo Vitamínico B/uso terapéutico , Adenocarcinoma/epidemiología , Adulto , Anciano , Consumo de Bebidas Alcohólicas , Australia/epidemiología , Esófago de Barrett/epidemiología , Esófago de Barrett/patología , Betaína/uso terapéutico , Carcinoma de Células Escamosas/prevención & control , Estudios de Casos y Controles , Suplementos Dietéticos/efectos adversos , Neoplasias Esofágicas/epidemiología , Esófago/patología , Femenino , Ácido Fólico/administración & dosificación , Ácido Fólico/efectos adversos , Humanos , Modelos Logísticos , Masculino , Metionina/efectos adversos , Persona de Mediana Edad , Factores de Riesgo , Fumar , Complejo Vitamínico B/administración & dosificación , Complejo Vitamínico B/efectos adversos
11.
Eur J Cancer ; 43(18): 2707-16, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17988857

RESUMEN

To investigate the associations between intake of antioxidant nutrients and risk of basal cell (BCC) and squamous cell carcinomas (SCC) of the skin, we carried out a prospective study among 1001 randomly selected adults living in an Australian community. Intake of antioxidants was estimated in 1996. Incident, histologically-confirmed BCC and SCC were recorded between 1996 and 2004. High dietary intake of lutein and zeaxanthin was associated with a reduced incidence of SCC in persons who had a history of skin cancer at baseline (highest versus lowest tertile, multivariable adjusted relative risk (RR)=0.47, 95% confidence interval (CI): 0.25-0.89; P for trend=0.02). In persons without a history of skin cancer at baseline, development of BCC was positively associated with intake of vitamins C and E from foods plus supplements (RR=3.1, 95% CI: 1.1-8.6; P for trend=0.03 and RR=2.6, 95% CI: 1.1-6.3; P for trend=0.02, respectively). In those with a skin cancer history at baseline, dietary intake in the second tertile for beta-carotene (multivariable adjusted RR=2.2, 95% CI: 1.2-4.1) and for vitamin E (multivariable adjusted RR=2.1, 95% CI: 1.1-3.9) was associated with increased BCC risk, with no trend, and similar results were seen in those with a specific history of BCC. These data suggest quite different associations between antioxidant intake and SCC compared with BCC, consistent with other evidence of their different causal pathways.


Asunto(s)
Antioxidantes/administración & dosificación , Carcinoma Basocelular/epidemiología , Carcinoma de Células Escamosas/epidemiología , Neoplasias Cutáneas/epidemiología , Anciano , Ácido Ascórbico/administración & dosificación , Carotenoides/administración & dosificación , Métodos Epidemiológicos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Queensland/epidemiología , Selenio/administración & dosificación , Vitamina E/administración & dosificación
12.
Public Health Nutr ; 9(3): 394-402, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16684392

RESUMEN

OBJECTIVE: To assess validity of the Nambour food-frequency questionnaire (FFQ) relative to weighed food records (WFRs), and the extent to which selected demographic, anthropometric and social characteristics explain differences between the two dietary methods. DESIGN: Inter-method validity study; 129-item FFQ vs. 12 days of WFR over 12 months. SETTING: Community-based Nambour Skin Cancer Prevention Trial. SUBJECTS: One hundred and fifteen of 168 randomly selected participants in the trial (68% acceptance rate) aged 25-75 years. RESULTS: Spearman correlations between intakes from the two methods ranged from 0.18 to 0.71 for energy-adjusted values. Differences between FFQ and WFR regressed on personal characteristics were significantly associated with at least one characteristic for 16 of the 21 nutrients. Sex was significantly associated with differences for nine nutrients; body mass index (BMI), presence of any medical condition and age were each significantly associated with differences for three to six nutrients; use of dietary supplements and occupation were associated with differences for one nutrient each. There was no consistency in the direction of the significant associations. Regression models explained from 7% (riboflavin) to 27% (saturated fat) of variation in differences in intakes. CONCLUSIONS: The relative validity of FFQ estimates for many nutrients is quite different for males than for females. Age, BMI, medical condition and level of intake were also associated with relative validity for some nutrients, resulting in the need to adjust intakes estimates for these in modelling diet-disease relationships. Estimates for cholesterol, beta-carotene equivalents, retinol equivalents, thiamine, riboflavin and calcium would not benefit from this.


Asunto(s)
Estado de Salud , Evaluación Nutricional , Encuestas y Cuestionarios/normas , Adulto , Distribución por Edad , Anciano , Antropometría , Índice de Masa Corporal , Intervalos de Confianza , Demografía , Registros de Dieta , Encuestas sobre Dietas , Femenino , Humanos , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Distribución por Sexo , Estadísticas no Paramétricas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA